Skip Navigation



Carcinogenesis Advance Access published online on August 19, 2004

Carcinogenesis, doi:10.1093/carcin/bgh269
© 2004 by Oxford University Press
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
25/12/2519    most recent
bgh269v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Zhang, J.
Right arrow Articles by Dong, Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, J.
Right arrow Articles by Dong, Z.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Received May 30, 2004
Revised July 19, 2004
Accepted August 10, 2004

CARCINOGENESIS

The functional SNP in the matrix metalloproteinase-3 promoter modifies susceptibility and lymphatic metastases in esophageal squamous cell carcinoma but not in gastric cardiac adenocarcinoma

Jianhui Zhang 1*, Xia Jin 1, Shumei Fang 1, Yan Li 1, Rui Wang 2, Wei Guo 1, Na Wang 1, Yimin Wang 1, Denggui Wen 1, Lizhen Wei 1, Gang Kuang 1, Zhiming Dong 1

1 Hebei Cancer Institute, Hebei Medical University, Shijiazhuang 050011, Hebei Province, China
2 The Fourth Affiliated Hospital, Hebei Medical University, Shijiazhuang 050011, Hebei Province, China

* To whom correspondence should be addressed. E-mail: Jianhuizh{at}hotmail.com.


   Abstract

The matrix metalloproteinases (MMPs), a family of proteolytic enzymes that degrade different components of extracellular matrix, play important roles in tumor development and invasion. A single adenine insertion/deletion polymorphism (6A/5A) in the MMP3 promoter region causes transcriptional elevation. The aim of this study is to assess the effects of this single nucleotide polymorphism (SNP) on the development and clinical staging of esophageal squamous cell carcinoma (ESCC) and gastric cardiac adenocarcinoma (GCA). The MMP3 SNP was genotyped by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis in 417 cancer patients (234 ESCC and 183 GCA) and 350 controls in North China. The overall distribution of the MMP3 SNP in ESCC and GCA patients was not significantly different from that in healthy controls. However, smoking individuals with the 5A/5A or 5A/6A genotype in ESCC patients were significantly more common than in controls (37.5% versus 23.3%, {chi}2 = 5.13, P = 0.02). Thus, smokers with at least one 5A allele significantly increased the risk to ESCC, compared with those with the 6A homozygote (age and sex adjusted OR = 1.95, 95% CI = 1.08-3.53). The significant difference in the SNP distribution between ESCC, GCA patients and controls was not observed when stratified by family history of upper gastrointestinal cancer. In addition, the frequency of the 5A/5A+5A/6A genotypes in ESCC patients with and without lymphatic metastasis was significantly different (45.8% versus 27.8%, {chi}2 = 4.56, P = 0.03). Therefore, patients with at least one 5A allele significantly increased the prone of lymphatic metastasis in ESCC. In contrast, the significant difference in the SNP distribution between patients with and without lymphatic metastasis was not observed in GCA. The present study suggested that the MMP3 promoter SNP might be associated with risk of development and lymphatic metastasis in ESCC but not in GCA.

Keywords: esophageal squamous cell carcinoma; gastric cardiac adenocarcinoma; matrix metalloproteinase; polymorphism; susceptibility; lymphatic metastasis.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Mol Hum ReprodHome page
K. Shan, Z. Lian-Fu, D. Hui, G. Wei, W. Na, J. Xia, and L. Yan
Polymorphisms in the promoter regions of the matrix metalloproteinases-7, -9 and the risk of endometriosis and adenomyosis in China
Mol. Hum. Reprod., January 1, 2006; 12(1): 35 - 39.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
X. Ma, G. Ruan, Y. Wang, Q. Li, P. Zhu, Y.-Z. Qin, J.-L. Li, Y.-R. Liu, D. Ma, and H. Zhao
Two Single-Nucleotide Polymorphisms with Linkage Disequilibrium in the Human Programmed Cell Death 5 Gene 5' Regulatory Region Affect Promoter Activity and the Susceptibility of Chronic Myelogenous Leukemia in Chinese Population
Clin. Cancer Res., December 15, 2005; 11(24): 8592 - 8599.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. Zhang, X. Jin, S. Fang, R. Wang, Y. Li, N. Wang, W. Guo, Y. Wang, D. Wen, L. Wei, et al.
The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma
Carcinogenesis, October 1, 2005; 26(10): 1748 - 1753.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
Y. Zhou, C. Yu, X. Miao, Y. Wang, W. Tan, T. Sun, X. Zhang, P. Xiong, and D. Lin
Functional haplotypes in the promoter of matrix metalloproteinase-2 and lung cancer susceptibility
Carcinogenesis, June 1, 2005; 26(6): 1117 - 1121.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Fang, X. Jin, R. Wang, Y. Li, W. Guo, N. Wang, Y. Wang, D. Wen, L. Wei, and J. Zhang
Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China
Carcinogenesis, February 1, 2005; 26(2): 481 - 486.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.